Cargando…

Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study

BACKGROUND: We surveyed the occurrence of physical symptoms among long-term gynaecological cancer survivors after pelvic radiation therapy, and compared with population-based control women. METHODS: We identified a cohort of 789 eligible gynaecological cancer survivors treated with pelvic radiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind, H, Waldenström, A-C, Dunberger, G, al-Abany, M, Alevronta, E, Johansson, K-A, Olsson, C, Nyberg, T, Wilderäng, U, Steineck, G, Åvall-Lundqvist, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171018/
https://www.ncbi.nlm.nih.gov/pubmed/21847122
http://dx.doi.org/10.1038/bjc.2011.315
_version_ 1782211705244221440
author Lind, H
Waldenström, A-C
Dunberger, G
al-Abany, M
Alevronta, E
Johansson, K-A
Olsson, C
Nyberg, T
Wilderäng, U
Steineck, G
Åvall-Lundqvist, E
author_facet Lind, H
Waldenström, A-C
Dunberger, G
al-Abany, M
Alevronta, E
Johansson, K-A
Olsson, C
Nyberg, T
Wilderäng, U
Steineck, G
Åvall-Lundqvist, E
author_sort Lind, H
collection PubMed
description BACKGROUND: We surveyed the occurrence of physical symptoms among long-term gynaecological cancer survivors after pelvic radiation therapy, and compared with population-based control women. METHODS: We identified a cohort of 789 eligible gynaecological cancer survivors treated with pelvic radiation therapy alone or combined with surgery in Stockholm or Gothenburg, Sweden. A control group of 478 women was randomly sampled from the Swedish Population Registry. Data were collected through a study-specific validated postal questionnaire with 351 questions concerning gastrointestinal and urinary tract function, lymph oedema, pelvic bones and sexuality. Clinical characteristics and treatment details were retrieved from medical records. RESULTS: Participation rate was 78% for gynaecological cancer survivors and 72% for control women. Median follow-up time after treatment was 74 months. Cancer survivors reported a higher occurrence of symptoms from all organs studied. The highest age-adjusted relative risk (RR) was found for emptying of all stools into clothing without forewarning (RR 12.7), defaecation urgency (RR 5.7), difficulty feeling the need to empty the bladder (RR 2.8), protracted genital pain (RR 5.0), pubic pain when walking indoors (RR 4.9) and erysipelas on abdomen or legs at least once during the past 6 months (RR 3.6). Survivors treated with radiation therapy alone showed in general higher rates of symptoms. CONCLUSION: Gynaecological cancer survivors previously treated with pelvic radiation report a higher occurrence of symptoms from the urinary and gastrointestinal tract as well as lymph oedema, sexual dysfunction and pelvic pain compared with non-irradiated control women. Health-care providers need to actively ask patients about specific symptoms in order to provide proper diagnostic investigations and management.
format Online
Article
Text
id pubmed-3171018
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-31710182012-09-06 Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study Lind, H Waldenström, A-C Dunberger, G al-Abany, M Alevronta, E Johansson, K-A Olsson, C Nyberg, T Wilderäng, U Steineck, G Åvall-Lundqvist, E Br J Cancer Clinical Study BACKGROUND: We surveyed the occurrence of physical symptoms among long-term gynaecological cancer survivors after pelvic radiation therapy, and compared with population-based control women. METHODS: We identified a cohort of 789 eligible gynaecological cancer survivors treated with pelvic radiation therapy alone or combined with surgery in Stockholm or Gothenburg, Sweden. A control group of 478 women was randomly sampled from the Swedish Population Registry. Data were collected through a study-specific validated postal questionnaire with 351 questions concerning gastrointestinal and urinary tract function, lymph oedema, pelvic bones and sexuality. Clinical characteristics and treatment details were retrieved from medical records. RESULTS: Participation rate was 78% for gynaecological cancer survivors and 72% for control women. Median follow-up time after treatment was 74 months. Cancer survivors reported a higher occurrence of symptoms from all organs studied. The highest age-adjusted relative risk (RR) was found for emptying of all stools into clothing without forewarning (RR 12.7), defaecation urgency (RR 5.7), difficulty feeling the need to empty the bladder (RR 2.8), protracted genital pain (RR 5.0), pubic pain when walking indoors (RR 4.9) and erysipelas on abdomen or legs at least once during the past 6 months (RR 3.6). Survivors treated with radiation therapy alone showed in general higher rates of symptoms. CONCLUSION: Gynaecological cancer survivors previously treated with pelvic radiation report a higher occurrence of symptoms from the urinary and gastrointestinal tract as well as lymph oedema, sexual dysfunction and pelvic pain compared with non-irradiated control women. Health-care providers need to actively ask patients about specific symptoms in order to provide proper diagnostic investigations and management. Nature Publishing Group 2011-09-06 2011-08-16 /pmc/articles/PMC3171018/ /pubmed/21847122 http://dx.doi.org/10.1038/bjc.2011.315 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Lind, H
Waldenström, A-C
Dunberger, G
al-Abany, M
Alevronta, E
Johansson, K-A
Olsson, C
Nyberg, T
Wilderäng, U
Steineck, G
Åvall-Lundqvist, E
Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title_full Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title_fullStr Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title_full_unstemmed Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title_short Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
title_sort late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171018/
https://www.ncbi.nlm.nih.gov/pubmed/21847122
http://dx.doi.org/10.1038/bjc.2011.315
work_keys_str_mv AT lindh latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT waldenstromac latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT dunbergerg latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT alabanym latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT alevrontae latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT johanssonka latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT olssonc latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT nybergt latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT wilderangu latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT steineckg latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy
AT avalllundqviste latesymptomsinlongtermgynaecologicalcancersurvivorsafterradiationtherapyapopulationbasedcohortstudy